寿仙谷(603896) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was CNY 206,156,004.83, representing a year-on-year increase of 1.20%[4] - The net profit attributable to shareholders for Q1 2023 was CNY 62,610,490.08, reflecting a growth of 6.13% compared to the same period last year[4] - The basic earnings per share for Q1 2023 was CNY 0.32, which is an increase of 6.67% year-on-year[5] - Total operating revenue for Q1 2023 was CNY 206,156,004.83, a slight increase of 0.21% compared to CNY 203,720,149.88 in Q1 2022[19] - Net profit for Q1 2023 reached CNY 62,610,490.08, representing an increase of 2.47% from CNY 59,142,082.00 in Q1 2022[20] - Earnings per share for Q1 2023 were CNY 0.32, compared to CNY 0.30 in Q1 2022, reflecting a growth of 6.67%[20] - Other comprehensive income after tax for Q1 2023 was CNY 5,723,141.98, compared to CNY 4,875,301.97 in Q1 2022, indicating a growth of 17.38%[20] Assets and Liabilities - The total assets at the end of Q1 2023 amounted to CNY 2,984,851,552.15, up 4.50% from the end of the previous year[5] - As of March 31, 2023, the total assets of Zhejiang Shuxian Valley Pharmaceutical Co., Ltd. amounted to CNY 2,984,851,552.15, an increase from CNY 2,856,189,559.66 at the end of 2022, reflecting a growth of approximately 4.5%[14] - The company's cash and cash equivalents reached CNY 1,624,310,541.31, up from CNY 1,524,712,390.54 at the end of 2022, indicating an increase of about 6.5%[14] - Inventory levels increased to CNY 164,854,744.62 from CNY 147,756,333.74, representing a rise of approximately 11.6%[14] - The total liabilities of the company increased to CNY 951,224,146.27 from CNY 890,354,337.34, reflecting a growth of about 6.8%[15] - Total liabilities as of Q1 2023 were CNY 1,010,947,011.71, an increase of 6.34% from CNY 950,667,244.96 in Q1 2022[19] Cash Flow - The net cash flow from operating activities for Q1 2023 was CNY 78,770,447.68, showing a decrease of 3.13% compared to the previous year[4] - Cash flow from operating activities for Q1 2023 was CNY 78,770,447.68, a decrease of 3.09% from CNY 81,311,500.62 in Q1 2022[21] - Cash inflow from operating activities totaled CNY 242,844,419.45 in Q1 2023, an increase of 8.14% from CNY 224,529,100.62 in Q1 2022[21] - In Q1 2023, the net cash flow from investing activities was -$48,674,579.89, compared to -$47,430,058.40 in the previous year[23] - The total cash inflow from financing activities was $302,925,760.00, with cash outflow totaling $308,423,477.02, resulting in a net cash flow of -$5,497,717.02[23] - The cash generated from financing activities included $187,925,760.00 from borrowings and $115,000,000.00 from other financing activities[23] - The net increase in cash and cash equivalents for Q1 2023 was $24,598,150.77, compared to $27,686,518.37 in the previous year[23] Shareholder Information - The company reported a total of 15,244 common shareholders at the end of the reporting period[10] - The top shareholder, Zhejiang Shouxian Valley Investment Management Co., Ltd., holds 28.76% of the shares, amounting to 56,711,239 shares[10] Other Financial Metrics - The weighted average return on equity for Q1 2023 was 3.23%, a decrease of 0.34 percentage points year-on-year[5] - The total current liabilities increased to CNY 531,550,902.54 from CNY 477,765,151.63, reflecting a growth of about 11.2%[15] - The company's long-term investments in equity increased slightly to CNY 5,988,270.17 from CNY 5,927,692.09, showing a growth of approximately 1.0%[14] - The non-current assets totaled CNY 1,015,937,901.80, up from CNY 994,178,202.27, indicating an increase of about 2.5%[15] - The company's accounts receivable decreased to CNY 88,648,652.43 from CNY 113,660,007.77, a decline of approximately 22.0%[14] - Research and development expenses for Q1 2023 were CNY 11,429,365.94, an increase of 5.68% from CNY 10,816,003.23 in Q1 2022[19] Prepayments - The company experienced a significant increase in prepayments, with a rise of 117.20% in advance payments received during the reporting period[8] - The company reported a significant increase in prepayments to CNY 15,193,252.07 from CNY 13,965,241.53, which is an increase of approximately 8.8%[14] Accounting Standards - The company did not apply new accounting standards or interpretations for the first time in 2023[25]